B&G Foods (BGS) Q3 2024 earnings summary

Executive summary

• Net sales for Q3 2024 declined 8.3% year-over-year to $461.1 million, primarily due to the Green Giant U.S. shelf-stable divestiture, lower unit volumes, and negative foreign currency impact, partially offset by improved pricing and product mix.

• Net income for Q3 2024 was $7.5 million, a significant improvement from a net loss of $82.7 million in Q3 2023, mainly due to the absence of prior year impairment charges.

• Portfolio reshaping remains a priority, with completed divestitures of Green Giant U.S. shelf-stable and Back to Nature businesses, and ongoing reviews for further non-core asset sales.

• Spices and flavor solutions showed positive growth, while other segments faced volume and pricing pressures, especially in specialty and meals.

Financial highlights

• Q3 2024 adjusted EBITDA was $70.4 million (15.3% of net sales), down from $80.4 million (16%) in Q3 2023.

• Adjusted gross profit was $102.4 million (22.2% of net sales), down from $114.1 million (22.7%) year-over-year.

• Net interest expense increased to $42.2 million from $35.9 million year-over-year due to higher rates and refinancing costs.

• For the first three quarters of 2024, net sales were $1,380.9 million, down 7.0% year-over-year; net loss was $28.8 million, improved from a $68.8 million loss in the prior year.

Outlook and guidance

• Fiscal 2024 guidance revised: net sales $1.92–$1.95 billion, adjusted EBITDA $295–$305 million, adjusted EPS $0.67–$0.77.

• Q4 base business net sales expected to decline 2–3% year-over-year, mirroring Q3 trends.

• Management expects gradual recovery and stabilization in 2025, with sequential improvement between first and second halves.

• Full-year 2024 interest expense expected at $152.5–$157.5 million; CapEx $30–$35 million.

• Aggregate dividend payments of approximately $60.2 million anticipated in fiscal 2025.